nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Betamethasone—hematologic cancer	0.0964	0.174	CbGbCtD
Nimodipine—NR3C2—Prednisolone—hematologic cancer	0.0951	0.172	CbGbCtD
Nimodipine—NR3C2—Dexamethasone—hematologic cancer	0.0561	0.101	CbGbCtD
Nimodipine—CYP3A5—Daunorubicin—hematologic cancer	0.021	0.0379	CbGbCtD
Nimodipine—CYP3A5—Thalidomide—hematologic cancer	0.0191	0.0345	CbGbCtD
Nimodipine—CYP3A5—Teniposide—hematologic cancer	0.0183	0.0329	CbGbCtD
Nimodipine—CYP3A5—Ifosfamide—hematologic cancer	0.0168	0.0304	CbGbCtD
Nimodipine—CYP3A5—Imatinib—hematologic cancer	0.0161	0.029	CbGbCtD
Nimodipine—CYP3A4—Bexarotene—hematologic cancer	0.014	0.0252	CbGbCtD
Nimodipine—CYP3A4—Busulfan—hematologic cancer	0.013	0.0234	CbGbCtD
Nimodipine—CYP3A4—Lomustine—hematologic cancer	0.013	0.0234	CbGbCtD
Nimodipine—CYP3A5—Dasatinib—hematologic cancer	0.0129	0.0233	CbGbCtD
Nimodipine—CYP3A4—Thiotepa—hematologic cancer	0.0116	0.0209	CbGbCtD
Nimodipine—CYP3A5—Irinotecan—hematologic cancer	0.0101	0.0181	CbGbCtD
Nimodipine—CYP3A4—Methoxsalen—hematologic cancer	0.009	0.0163	CbGbCtD
Nimodipine—CYP3A5—Vincristine—hematologic cancer	0.00878	0.0159	CbGbCtD
Nimodipine—CYP3A4—Bortezomib—hematologic cancer	0.00856	0.0155	CbGbCtD
Nimodipine—CYP3A4—Daunorubicin—hematologic cancer	0.00819	0.0148	CbGbCtD
Nimodipine—CYP3A5—Etoposide—hematologic cancer	0.00805	0.0145	CbGbCtD
Nimodipine—CYP3A4—Cytarabine—hematologic cancer	0.00723	0.013	CbGbCtD
Nimodipine—CYP3A4—Teniposide—hematologic cancer	0.00712	0.0128	CbGbCtD
Nimodipine—CYP3A5—Dexamethasone—hematologic cancer	0.00662	0.0119	CbGbCtD
Nimodipine—CYP3A4—Ifosfamide—hematologic cancer	0.00657	0.0119	CbGbCtD
Nimodipine—CYP3A4—Imatinib—hematologic cancer	0.00627	0.0113	CbGbCtD
Nimodipine—CYP3A4—Ruxolitinib—hematologic cancer	0.00591	0.0107	CbGbCtD
Nimodipine—CYP3A4—Nilotinib—hematologic cancer	0.0057	0.0103	CbGbCtD
Nimodipine—CYP3A4—Vinorelbine—hematologic cancer	0.00565	0.0102	CbGbCtD
Nimodipine—CYP3A4—Triamcinolone—hematologic cancer	0.00517	0.00933	CbGbCtD
Nimodipine—CYP3A4—Dasatinib—hematologic cancer	0.00504	0.0091	CbGbCtD
Nimodipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00498	0.00899	CbGbCtD
Nimodipine—CYP3A4—Betamethasone—hematologic cancer	0.00444	0.00801	CbGbCtD
Nimodipine—CYP3A4—Prednisolone—hematologic cancer	0.00438	0.0079	CbGbCtD
Nimodipine—CYP3A4—Prednisone—hematologic cancer	0.00413	0.00746	CbGbCtD
Nimodipine—CYP3A4—Irinotecan—hematologic cancer	0.00392	0.00707	CbGbCtD
Nimodipine—CYP3A4—Vinblastine—hematologic cancer	0.00348	0.00629	CbGbCtD
Nimodipine—CYP3A4—Vincristine—hematologic cancer	0.00343	0.00618	CbGbCtD
Nimodipine—CYP3A4—Etoposide—hematologic cancer	0.00314	0.00567	CbGbCtD
Nimodipine—CYP3A4—Dexamethasone—hematologic cancer	0.00258	0.00466	CbGbCtD
Nimodipine—CACNB4—lung—hematologic cancer	0.00258	0.0632	CbGeAlD
Nimodipine—CACNB4—testis—hematologic cancer	0.00243	0.0596	CbGeAlD
Nimodipine—CACNB3—blood—hematologic cancer	0.00225	0.0552	CbGeAlD
Nimodipine—CYP3A4—Doxorubicin—hematologic cancer	0.00214	0.00386	CbGbCtD
Nimodipine—CACNB3—lung—hematologic cancer	0.00197	0.0484	CbGeAlD
Nimodipine—CACNB1—testis—hematologic cancer	0.00194	0.0476	CbGeAlD
Nimodipine—CACNB3—testis—hematologic cancer	0.00186	0.0457	CbGeAlD
Nimodipine—NR3C2—hematopoietic system—hematologic cancer	0.00168	0.0411	CbGeAlD
Nimodipine—AHR—blood—hematologic cancer	0.00167	0.0409	CbGeAlD
Nimodipine—AHR—bone marrow—hematologic cancer	0.00161	0.0396	CbGeAlD
Nimodipine—AHR—lung—hematologic cancer	0.00146	0.0359	CbGeAlD
Nimodipine—CACNB1—lymph node—hematologic cancer	0.00141	0.0345	CbGeAlD
Nimodipine—AHR—testis—hematologic cancer	0.00138	0.0338	CbGeAlD
Nimodipine—CACNB3—lymph node—hematologic cancer	0.00135	0.0331	CbGeAlD
Nimodipine—CACNB2—lung—hematologic cancer	0.00133	0.0325	CbGeAlD
Nimodipine—CACNB2—testis—hematologic cancer	0.00125	0.0307	CbGeAlD
Nimodipine—CACNA1D—lung—hematologic cancer	0.00116	0.0284	CbGeAlD
Nimodipine—NR3C2—blood—hematologic cancer	0.00111	0.0273	CbGeAlD
Nimodipine—CACNA1D—testis—hematologic cancer	0.00109	0.0268	CbGeAlD
Nimodipine—CACNA1C—lung—hematologic cancer	0.00107	0.0262	CbGeAlD
Nimodipine—CACNA1C—testis—hematologic cancer	0.00101	0.0248	CbGeAlD
Nimodipine—AHR—lymph node—hematologic cancer	0.001	0.0245	CbGeAlD
Nimodipine—NR3C2—lung—hematologic cancer	0.000973	0.0239	CbGeAlD
Nimodipine—NR3C2—testis—hematologic cancer	0.000919	0.0225	CbGeAlD
Nimodipine—CACNB2—lymph node—hematologic cancer	0.000907	0.0222	CbGeAlD
Nimodipine—CYP3A5—hematopoietic system—hematologic cancer	0.000906	0.0222	CbGeAlD
Nimodipine—CACNA1D—lymph node—hematologic cancer	0.000792	0.0194	CbGeAlD
Nimodipine—CACNA1C—lymph node—hematologic cancer	0.000731	0.018	CbGeAlD
Nimodipine—CYP3A4—hematopoietic system—hematologic cancer	0.00068	0.0167	CbGeAlD
Nimodipine—NR3C2—lymph node—hematologic cancer	0.000666	0.0163	CbGeAlD
Nimodipine—CYP3A5—blood—hematologic cancer	0.0006	0.0147	CbGeAlD
Nimodipine—CYP3A5—lung—hematologic cancer	0.000526	0.0129	CbGeAlD
Nimodipine—CYP3A4—blood—hematologic cancer	0.00045	0.0111	CbGeAlD
Nimodipine—Nifedipine—ABCC3—hematologic cancer	0.00041	0.42	CrCbGaD
Nimodipine—Nisoldipine—ABCB1—hematologic cancer	0.000115	0.118	CrCbGaD
Nimodipine—Nitrendipine—ABCB1—hematologic cancer	0.000108	0.11	CrCbGaD
Nimodipine—Amlodipine—ABCB1—hematologic cancer	9.27e-05	0.095	CrCbGaD
Nimodipine—Hypersensitivity—Ifosfamide—hematologic cancer	8.59e-05	0.000356	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	8.57e-05	0.000355	CcSEcCtD
Nimodipine—Felodipine—ABCB1—hematologic cancer	8.57e-05	0.0879	CrCbGaD
Nimodipine—Vomiting—Vinorelbine—hematologic cancer	8.53e-05	0.000354	CcSEcCtD
Nimodipine—Diarrhoea—Thalidomide—hematologic cancer	8.48e-05	0.000352	CcSEcCtD
Nimodipine—Dizziness—Thiotepa—hematologic cancer	8.48e-05	0.000352	CcSEcCtD
Nimodipine—Rash—Vinorelbine—hematologic cancer	8.46e-05	0.000351	CcSEcCtD
Nimodipine—Dermatitis—Vinorelbine—hematologic cancer	8.45e-05	0.000351	CcSEcCtD
Nimodipine—Angiopathy—Prednisone—hematologic cancer	8.43e-05	0.00035	CcSEcCtD
Nimodipine—Headache—Vinorelbine—hematologic cancer	8.41e-05	0.000349	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—hematologic cancer	8.39e-05	0.000348	CcSEcCtD
Nimodipine—Hypersensitivity—Vincristine—hematologic cancer	8.37e-05	0.000347	CcSEcCtD
Nimodipine—Oedema—Triamcinolone—hematologic cancer	8.35e-05	0.000346	CcSEcCtD
Nimodipine—Pruritus—Alitretinoin—hematologic cancer	8.34e-05	0.000346	CcSEcCtD
Nimodipine—Nifedipine—ABCB1—hematologic cancer	8.28e-05	0.085	CrCbGaD
Nimodipine—Pruritus—Ifosfamide—hematologic cancer	8.25e-05	0.000342	CcSEcCtD
Nimodipine—Dyspnoea—Etoposide—hematologic cancer	8.21e-05	0.000341	CcSEcCtD
Nimodipine—Dizziness—Thalidomide—hematologic cancer	8.2e-05	0.00034	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—hematologic cancer	8.18e-05	0.000339	CcSEcCtD
Nimodipine—Nausea—Bortezomib—hematologic cancer	8.16e-05	0.000339	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—hematologic cancer	8.16e-05	0.0836	CrCbGaD
Nimodipine—Hypersensitivity—Mitoxantrone—hematologic cancer	8.15e-05	0.000338	CcSEcCtD
Nimodipine—Hypersensitivity—Irinotecan—hematologic cancer	8.15e-05	0.000338	CcSEcCtD
Nimodipine—Tachycardia—Triamcinolone—hematologic cancer	8.15e-05	0.000338	CcSEcCtD
Nimodipine—Vomiting—Thiotepa—hematologic cancer	8.15e-05	0.000338	CcSEcCtD
Nimodipine—Diarrhoea—Carmustine—hematologic cancer	8.15e-05	0.000338	CcSEcCtD
Nimodipine—Nausea—Bleomycin—hematologic cancer	8.1e-05	0.000336	CcSEcCtD
Nimodipine—Rash—Thiotepa—hematologic cancer	8.08e-05	0.000335	CcSEcCtD
Nimodipine—Dermatitis—Thiotepa—hematologic cancer	8.07e-05	0.000335	CcSEcCtD
Nimodipine—Hyperhidrosis—Triamcinolone—hematologic cancer	8.07e-05	0.000335	CcSEcCtD
Nimodipine—Diarrhoea—Alitretinoin—hematologic cancer	8.07e-05	0.000335	CcSEcCtD
Nimodipine—Headache—Thiotepa—hematologic cancer	8.03e-05	0.000333	CcSEcCtD
Nimodipine—Hypertension—Betamethasone—hematologic cancer	8.02e-05	0.000333	CcSEcCtD
Nimodipine—Hypertension—Dexamethasone—hematologic cancer	8.02e-05	0.000333	CcSEcCtD
Nimodipine—Diarrhoea—Ifosfamide—hematologic cancer	7.98e-05	0.000331	CcSEcCtD
Nimodipine—Nausea—Vinorelbine—hematologic cancer	7.97e-05	0.000331	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—hematologic cancer	7.95e-05	0.00033	CcSEcCtD
Nimodipine—Myalgia—Betamethasone—hematologic cancer	7.9e-05	0.000328	CcSEcCtD
Nimodipine—Myalgia—Dexamethasone—hematologic cancer	7.9e-05	0.000328	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—hematologic cancer	7.89e-05	0.000327	CcSEcCtD
Nimodipine—Vomiting—Thalidomide—hematologic cancer	7.88e-05	0.000327	CcSEcCtD
Nimodipine—Dizziness—Carmustine—hematologic cancer	7.87e-05	0.000327	CcSEcCtD
Nimodipine—Rash—Thalidomide—hematologic cancer	7.82e-05	0.000324	CcSEcCtD
Nimodipine—Dermatitis—Thalidomide—hematologic cancer	7.81e-05	0.000324	CcSEcCtD
Nimodipine—Dizziness—Alitretinoin—hematologic cancer	7.8e-05	0.000324	CcSEcCtD
Nimodipine—Diarrhoea—Vincristine—hematologic cancer	7.78e-05	0.000323	CcSEcCtD
Nimodipine—Headache—Thalidomide—hematologic cancer	7.77e-05	0.000322	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—hematologic cancer	7.76e-05	0.000322	CcSEcCtD
Nimodipine—Dizziness—Ifosfamide—hematologic cancer	7.71e-05	0.00032	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—hematologic cancer	7.65e-05	0.000317	CcSEcCtD
Nimodipine—Pruritus—Gemcitabine—hematologic cancer	7.63e-05	0.000316	CcSEcCtD
Nimodipine—Nausea—Thiotepa—hematologic cancer	7.61e-05	0.000316	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.61e-05	0.000316	CcSEcCtD
Nimodipine—Oedema—Dexamethasone—hematologic cancer	7.58e-05	0.000314	CcSEcCtD
Nimodipine—Oedema—Betamethasone—hematologic cancer	7.58e-05	0.000314	CcSEcCtD
Nimodipine—Diarrhoea—Mitoxantrone—hematologic cancer	7.57e-05	0.000314	CcSEcCtD
Nimodipine—Diarrhoea—Irinotecan—hematologic cancer	7.57e-05	0.000314	CcSEcCtD
Nimodipine—Vomiting—Carmustine—hematologic cancer	7.57e-05	0.000314	CcSEcCtD
Nimodipine—Dizziness—Vincristine—hematologic cancer	7.52e-05	0.000312	CcSEcCtD
Nimodipine—Rash—Carmustine—hematologic cancer	7.51e-05	0.000311	CcSEcCtD
Nimodipine—Dermatitis—Carmustine—hematologic cancer	7.5e-05	0.000311	CcSEcCtD
Nimodipine—Vomiting—Alitretinoin—hematologic cancer	7.5e-05	0.000311	CcSEcCtD
Nimodipine—Anaemia—Prednisone—hematologic cancer	7.47e-05	0.00031	CcSEcCtD
Nimodipine—Headache—Carmustine—hematologic cancer	7.46e-05	0.000309	CcSEcCtD
Nimodipine—Dyspnoea—Triamcinolone—hematologic cancer	7.45e-05	0.000309	CcSEcCtD
Nimodipine—Rash—Alitretinoin—hematologic cancer	7.44e-05	0.000309	CcSEcCtD
Nimodipine—Nervous system disorder—Dexamethasone—hematologic cancer	7.43e-05	0.000308	CcSEcCtD
Nimodipine—Nervous system disorder—Betamethasone—hematologic cancer	7.43e-05	0.000308	CcSEcCtD
Nimodipine—Dermatitis—Alitretinoin—hematologic cancer	7.43e-05	0.000308	CcSEcCtD
Nimodipine—Thrombocytopenia—Betamethasone—hematologic cancer	7.42e-05	0.000308	CcSEcCtD
Nimodipine—Thrombocytopenia—Dexamethasone—hematologic cancer	7.42e-05	0.000308	CcSEcCtD
Nimodipine—Vomiting—Ifosfamide—hematologic cancer	7.41e-05	0.000307	CcSEcCtD
Nimodipine—Hypersensitivity—Cisplatin—hematologic cancer	7.4e-05	0.000307	CcSEcCtD
Nimodipine—Tachycardia—Dexamethasone—hematologic cancer	7.4e-05	0.000307	CcSEcCtD
Nimodipine—Tachycardia—Betamethasone—hematologic cancer	7.4e-05	0.000307	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—hematologic cancer	7.4e-05	0.000307	CcSEcCtD
Nimodipine—Headache—Alitretinoin—hematologic cancer	7.39e-05	0.000307	CcSEcCtD
Nimodipine—Diarrhoea—Gemcitabine—hematologic cancer	7.38e-05	0.000306	CcSEcCtD
Nimodipine—Nausea—Thalidomide—hematologic cancer	7.36e-05	0.000305	CcSEcCtD
Nimodipine—Rash—Ifosfamide—hematologic cancer	7.35e-05	0.000305	CcSEcCtD
Nimodipine—Dermatitis—Ifosfamide—hematologic cancer	7.34e-05	0.000305	CcSEcCtD
Nimodipine—Hyperhidrosis—Dexamethasone—hematologic cancer	7.33e-05	0.000304	CcSEcCtD
Nimodipine—Hyperhidrosis—Betamethasone—hematologic cancer	7.33e-05	0.000304	CcSEcCtD
Nimodipine—Dizziness—Irinotecan—hematologic cancer	7.32e-05	0.000304	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—hematologic cancer	7.3e-05	0.000303	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—hematologic cancer	7.26e-05	0.000301	CcSEcCtD
Nimodipine—Vomiting—Vincristine—hematologic cancer	7.23e-05	0.0003	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—hematologic cancer	7.2e-05	0.000299	CcSEcCtD
Nimodipine—Rash—Vincristine—hematologic cancer	7.17e-05	0.000297	CcSEcCtD
Nimodipine—Dermatitis—Vincristine—hematologic cancer	7.16e-05	0.000297	CcSEcCtD
Nimodipine—Headache—Vincristine—hematologic cancer	7.12e-05	0.000295	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—hematologic cancer	7.08e-05	0.000294	CcSEcCtD
Nimodipine—Hypotension—Betamethasone—hematologic cancer	7.08e-05	0.000294	CcSEcCtD
Nimodipine—Hypotension—Dexamethasone—hematologic cancer	7.08e-05	0.000294	CcSEcCtD
Nimodipine—Nausea—Carmustine—hematologic cancer	7.07e-05	0.000293	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—hematologic cancer	7.04e-05	0.000292	CcSEcCtD
Nimodipine—Vomiting—Irinotecan—hematologic cancer	7.04e-05	0.000292	CcSEcCtD
Nimodipine—Vomiting—Mitoxantrone—hematologic cancer	7.04e-05	0.000292	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—hematologic cancer	7.01e-05	0.000291	CcSEcCtD
Nimodipine—Nausea—Alitretinoin—hematologic cancer	7.01e-05	0.000291	CcSEcCtD
Nimodipine—Hypertension—Prednisone—hematologic cancer	6.98e-05	0.00029	CcSEcCtD
Nimodipine—Rash—Mitoxantrone—hematologic cancer	6.98e-05	0.00029	CcSEcCtD
Nimodipine—Rash—Irinotecan—hematologic cancer	6.98e-05	0.00029	CcSEcCtD
Nimodipine—Dermatitis—Mitoxantrone—hematologic cancer	6.97e-05	0.000289	CcSEcCtD
Nimodipine—Dermatitis—Irinotecan—hematologic cancer	6.97e-05	0.000289	CcSEcCtD
Nimodipine—Headache—Mitoxantrone—hematologic cancer	6.93e-05	0.000288	CcSEcCtD
Nimodipine—Headache—Irinotecan—hematologic cancer	6.93e-05	0.000288	CcSEcCtD
Nimodipine—Nausea—Ifosfamide—hematologic cancer	6.92e-05	0.000287	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.9e-05	0.000286	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.9e-05	0.000286	CcSEcCtD
Nimodipine—Myalgia—Prednisone—hematologic cancer	6.88e-05	0.000286	CcSEcCtD
Nimodipine—Diarrhoea—Cisplatin—hematologic cancer	6.88e-05	0.000285	CcSEcCtD
Nimodipine—Vomiting—Gemcitabine—hematologic cancer	6.86e-05	0.000284	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—hematologic cancer	6.84e-05	0.000284	CcSEcCtD
Nimodipine—Rash—Gemcitabine—hematologic cancer	6.8e-05	0.000282	CcSEcCtD
Nimodipine—Dermatitis—Gemcitabine—hematologic cancer	6.79e-05	0.000282	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—hematologic cancer	6.78e-05	0.000281	CcSEcCtD
Nimodipine—Headache—Gemcitabine—hematologic cancer	6.75e-05	0.00028	CcSEcCtD
Nimodipine—Nausea—Vincristine—hematologic cancer	6.75e-05	0.00028	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—hematologic cancer	6.74e-05	0.00028	CcSEcCtD
Nimodipine—Flushing—Epirubicin—hematologic cancer	6.74e-05	0.00028	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—hematologic cancer	6.72e-05	0.000279	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisolone—hematologic cancer	6.69e-05	0.000278	CcSEcCtD
Nimodipine—Oedema—Prednisone—hematologic cancer	6.6e-05	0.000274	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—hematologic cancer	6.59e-05	0.000273	CcSEcCtD
Nimodipine—Nausea—Mitoxantrone—hematologic cancer	6.57e-05	0.000273	CcSEcCtD
Nimodipine—Nausea—Irinotecan—hematologic cancer	6.57e-05	0.000273	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—hematologic cancer	6.56e-05	0.000272	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Nimodipine—Pruritus—Etoposide—hematologic cancer	6.51e-05	0.00027	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—hematologic cancer	6.47e-05	0.000268	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—hematologic cancer	6.44e-05	0.000267	CcSEcCtD
Nimodipine—Nausea—Gemcitabine—hematologic cancer	6.4e-05	0.000266	CcSEcCtD
Nimodipine—Vomiting—Cisplatin—hematologic cancer	6.39e-05	0.000265	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—hematologic cancer	6.38e-05	0.000265	CcSEcCtD
Nimodipine—Rash—Cisplatin—hematologic cancer	6.34e-05	0.000263	CcSEcCtD
Nimodipine—Dermatitis—Cisplatin—hematologic cancer	6.33e-05	0.000263	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—hematologic cancer	6.3e-05	0.000261	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—hematologic cancer	6.25e-05	0.000259	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—hematologic cancer	6.24e-05	0.000259	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—hematologic cancer	6.24e-05	0.000259	CcSEcCtD
Nimodipine—Hypersensitivity—Triamcinolone—hematologic cancer	6.15e-05	0.000255	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—hematologic cancer	6.1e-05	0.000253	CcSEcCtD
Nimodipine—Dizziness—Etoposide—hematologic cancer	6.09e-05	0.000253	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—hematologic cancer	6.08e-05	0.000252	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—hematologic cancer	6.07e-05	0.000252	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.01e-05	0.000249	CcSEcCtD
Nimodipine—Dizziness—Prednisolone—hematologic cancer	6e-05	0.000249	CcSEcCtD
Nimodipine—Nausea—Cisplatin—hematologic cancer	5.97e-05	0.000248	CcSEcCtD
Nimodipine—Pruritus—Triamcinolone—hematologic cancer	5.91e-05	0.000245	CcSEcCtD
Nimodipine—Vomiting—Etoposide—hematologic cancer	5.85e-05	0.000243	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—hematologic cancer	5.84e-05	0.000242	CcSEcCtD
Nimodipine—Rash—Etoposide—hematologic cancer	5.81e-05	0.000241	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—hematologic cancer	5.8e-05	0.000241	CcSEcCtD
Nimodipine—Headache—Etoposide—hematologic cancer	5.77e-05	0.000239	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—hematologic cancer	5.75e-05	0.000239	CcSEcCtD
Nimodipine—Rash—Prednisolone—hematologic cancer	5.73e-05	0.000238	CcSEcCtD
Nimodipine—Dermatitis—Prednisolone—hematologic cancer	5.72e-05	0.000237	CcSEcCtD
Nimodipine—Headache—Prednisolone—hematologic cancer	5.69e-05	0.000236	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—hematologic cancer	5.63e-05	0.000233	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—hematologic cancer	5.59e-05	0.000232	CcSEcCtD
Nimodipine—Dizziness—Triamcinolone—hematologic cancer	5.52e-05	0.000229	CcSEcCtD
Nimodipine—Nausea—Etoposide—hematologic cancer	5.47e-05	0.000227	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—hematologic cancer	5.46e-05	0.000226	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—hematologic cancer	5.41e-05	0.000224	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—hematologic cancer	5.41e-05	0.000224	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—hematologic cancer	5.4e-05	0.000224	CcSEcCtD
Nimodipine—Nausea—Prednisolone—hematologic cancer	5.39e-05	0.000224	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—hematologic cancer	5.38e-05	0.000223	CcSEcCtD
Nimodipine—Pruritus—Dexamethasone—hematologic cancer	5.36e-05	0.000222	CcSEcCtD
Nimodipine—Pruritus—Betamethasone—hematologic cancer	5.36e-05	0.000222	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—hematologic cancer	5.33e-05	0.000221	CcSEcCtD
Nimodipine—Vomiting—Triamcinolone—hematologic cancer	5.31e-05	0.00022	CcSEcCtD
Nimodipine—Rash—Triamcinolone—hematologic cancer	5.27e-05	0.000218	CcSEcCtD
Nimodipine—Dermatitis—Triamcinolone—hematologic cancer	5.26e-05	0.000218	CcSEcCtD
Nimodipine—Headache—Triamcinolone—hematologic cancer	5.23e-05	0.000217	CcSEcCtD
Nimodipine—Diarrhoea—Dexamethasone—hematologic cancer	5.18e-05	0.000215	CcSEcCtD
Nimodipine—Diarrhoea—Betamethasone—hematologic cancer	5.18e-05	0.000215	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—hematologic cancer	5.17e-05	0.000215	CcSEcCtD
Nimodipine—Oedema—Epirubicin—hematologic cancer	5.16e-05	0.000214	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—hematologic cancer	5.15e-05	0.000214	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—hematologic cancer	5.06e-05	0.00021	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—hematologic cancer	5.05e-05	0.00021	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—hematologic cancer	5.05e-05	0.00021	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—hematologic cancer	5.04e-05	0.000209	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.02e-05	0.000208	CcSEcCtD
Nimodipine—Dizziness—Dexamethasone—hematologic cancer	5.01e-05	0.000208	CcSEcCtD
Nimodipine—Dizziness—Betamethasone—hematologic cancer	5.01e-05	0.000208	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—hematologic cancer	4.99e-05	0.000207	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—hematologic cancer	4.98e-05	0.000207	CcSEcCtD
Nimodipine—Nausea—Triamcinolone—hematologic cancer	4.96e-05	0.000206	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—hematologic cancer	4.92e-05	0.000204	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisone—hematologic cancer	4.86e-05	0.000202	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—hematologic cancer	4.82e-05	0.0002	CcSEcCtD
Nimodipine—Vomiting—Betamethasone—hematologic cancer	4.82e-05	0.0002	CcSEcCtD
Nimodipine—Vomiting—Dexamethasone—hematologic cancer	4.82e-05	0.0002	CcSEcCtD
Nimodipine—Rash—Betamethasone—hematologic cancer	4.78e-05	0.000198	CcSEcCtD
Nimodipine—Rash—Dexamethasone—hematologic cancer	4.78e-05	0.000198	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—hematologic cancer	4.78e-05	0.000198	CcSEcCtD
Nimodipine—Dermatitis—Dexamethasone—hematologic cancer	4.77e-05	0.000198	CcSEcCtD
Nimodipine—Dermatitis—Betamethasone—hematologic cancer	4.77e-05	0.000198	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.76e-05	0.000198	CcSEcCtD
Nimodipine—Headache—Betamethasone—hematologic cancer	4.75e-05	0.000197	CcSEcCtD
Nimodipine—Headache—Dexamethasone—hematologic cancer	4.75e-05	0.000197	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.7e-05	0.000195	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—hematologic cancer	4.68e-05	0.000194	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—hematologic cancer	4.68e-05	0.000194	CcSEcCtD
Nimodipine—Pruritus—Prednisone—hematologic cancer	4.67e-05	0.000194	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—hematologic cancer	4.66e-05	0.000193	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—hematologic cancer	4.62e-05	0.000192	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—hematologic cancer	4.6e-05	0.000191	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—hematologic cancer	4.51e-05	0.000187	CcSEcCtD
Nimodipine—Nausea—Betamethasone—hematologic cancer	4.5e-05	0.000187	CcSEcCtD
Nimodipine—Nausea—Dexamethasone—hematologic cancer	4.5e-05	0.000187	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—hematologic cancer	4.46e-05	0.000185	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.46e-05	0.000185	CcSEcCtD
Nimodipine—Dizziness—Prednisone—hematologic cancer	4.36e-05	0.000181	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.35e-05	0.00018	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—hematologic cancer	4.26e-05	0.000177	CcSEcCtD
Nimodipine—Vomiting—Prednisone—hematologic cancer	4.2e-05	0.000174	CcSEcCtD
Nimodipine—Rash—Prednisone—hematologic cancer	4.16e-05	0.000173	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—hematologic cancer	4.16e-05	0.000172	CcSEcCtD
Nimodipine—Headache—Prednisone—hematologic cancer	4.13e-05	0.000171	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.12e-05	0.000171	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—hematologic cancer	4.06e-05	0.000169	CcSEcCtD
Nimodipine—Nausea—Prednisone—hematologic cancer	3.92e-05	0.000163	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—hematologic cancer	3.9e-05	0.000162	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—hematologic cancer	3.8e-05	0.000158	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—hematologic cancer	3.77e-05	0.000157	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—hematologic cancer	3.65e-05	0.000151	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—hematologic cancer	3.65e-05	0.000151	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—hematologic cancer	3.53e-05	0.000146	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—hematologic cancer	3.52e-05	0.000146	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—hematologic cancer	3.51e-05	0.000145	CcSEcCtD
Nimodipine—Rash—Methotrexate—hematologic cancer	3.48e-05	0.000144	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—hematologic cancer	3.47e-05	0.000144	CcSEcCtD
Nimodipine—Headache—Methotrexate—hematologic cancer	3.45e-05	0.000143	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—hematologic cancer	3.41e-05	0.000142	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—hematologic cancer	3.38e-05	0.00014	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—hematologic cancer	3.28e-05	0.000136	CcSEcCtD
Nimodipine—Nausea—Methotrexate—hematologic cancer	3.28e-05	0.000136	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—hematologic cancer	3.27e-05	0.000136	CcSEcCtD
Nimodipine—Rash—Epirubicin—hematologic cancer	3.25e-05	0.000135	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—hematologic cancer	3.25e-05	0.000135	CcSEcCtD
Nimodipine—Headache—Epirubicin—hematologic cancer	3.23e-05	0.000134	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Nimodipine—Nausea—Epirubicin—hematologic cancer	3.07e-05	0.000127	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—hematologic cancer	3.04e-05	0.000126	CcSEcCtD
Nimodipine—Rash—Doxorubicin—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Nimodipine—Headache—Doxorubicin—hematologic cancer	2.99e-05	0.000124	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—hematologic cancer	2.84e-05	0.000118	CcSEcCtD
Nimodipine—CACNA1C—Metabolism—GSTT1—hematologic cancer	1.5e-05	9.18e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD44—hematologic cancer	1.5e-05	9.17e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NQO1—hematologic cancer	1.5e-05	9.17e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—hematologic cancer	1.49e-05	9.15e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—hematologic cancer	1.49e-05	9.15e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CREBBP—hematologic cancer	1.49e-05	9.14e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—hematologic cancer	1.48e-05	9.06e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—hematologic cancer	1.48e-05	9.04e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—hematologic cancer	1.47e-05	9.04e-05	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—hematologic cancer	1.47e-05	9.03e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SDC1—hematologic cancer	1.46e-05	8.97e-05	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—hematologic cancer	1.46e-05	8.95e-05	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—hematologic cancer	1.45e-05	8.88e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—hematologic cancer	1.45e-05	8.87e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—hematologic cancer	1.44e-05	8.85e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—JAK2—hematologic cancer	1.44e-05	8.81e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CDA—hematologic cancer	1.43e-05	8.75e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NQO1—hematologic cancer	1.42e-05	8.68e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD44—hematologic cancer	1.42e-05	8.68e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYCS—hematologic cancer	1.42e-05	8.67e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK3—hematologic cancer	1.41e-05	8.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK3—hematologic cancer	1.41e-05	8.65e-05	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—hematologic cancer	1.41e-05	8.64e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HSP90AA1—hematologic cancer	1.41e-05	8.62e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—hematologic cancer	1.39e-05	8.54e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PC—hematologic cancer	1.37e-05	8.42e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—hematologic cancer	1.37e-05	8.4e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EP300—hematologic cancer	1.35e-05	8.28e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYCS—hematologic cancer	1.34e-05	8.21e-05	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—hematologic cancer	1.34e-05	8.19e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HSP90AA1—hematologic cancer	1.33e-05	8.16e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GBA—hematologic cancer	1.33e-05	8.13e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.33e-05	8.13e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SRC—hematologic cancer	1.31e-05	8.05e-05	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—hematologic cancer	1.3e-05	7.97e-05	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—hematologic cancer	1.3e-05	7.94e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CREBBP—hematologic cancer	1.29e-05	7.92e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—hematologic cancer	1.28e-05	7.84e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EP300—hematologic cancer	1.28e-05	7.84e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—hematologic cancer	1.28e-05	7.84e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—hematologic cancer	1.27e-05	7.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—hematologic cancer	1.27e-05	7.78e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—hematologic cancer	1.27e-05	7.77e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—hematologic cancer	1.26e-05	7.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.25e-05	7.66e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—hematologic cancer	1.25e-05	7.65e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD44—hematologic cancer	1.25e-05	7.63e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NQO1—hematologic cancer	1.25e-05	7.63e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SRC—hematologic cancer	1.25e-05	7.63e-05	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—hematologic cancer	1.24e-05	7.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.23e-05	7.55e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—hematologic cancer	1.23e-05	7.52e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CD—hematologic cancer	1.23e-05	7.51e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTAP—hematologic cancer	1.21e-05	7.44e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—hematologic cancer	1.21e-05	7.43e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK3—hematologic cancer	1.21e-05	7.42e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—hematologic cancer	1.21e-05	7.41e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—hematologic cancer	1.2e-05	7.36e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—hematologic cancer	1.2e-05	7.34e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—hematologic cancer	1.18e-05	7.24e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—hematologic cancer	1.18e-05	7.24e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYCS—hematologic cancer	1.18e-05	7.22e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—hematologic cancer	1.18e-05	7.2e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—hematologic cancer	1.18e-05	7.2e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HSP90AA1—hematologic cancer	1.17e-05	7.17e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3R1—hematologic cancer	1.16e-05	7.09e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.15e-05	7.04e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK3—hematologic cancer	1.15e-05	7.03e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NCOR1—hematologic cancer	1.15e-05	7.03e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—hematologic cancer	1.15e-05	7.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.13e-05	6.94e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EP300—hematologic cancer	1.13e-05	6.89e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—hematologic cancer	1.12e-05	6.85e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—hematologic cancer	1.11e-05	6.82e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—hematologic cancer	1.1e-05	6.72e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—hematologic cancer	1.09e-05	6.7e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—hematologic cancer	1.09e-05	6.67e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NCOR1—hematologic cancer	1.09e-05	6.65e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—hematologic cancer	1.09e-05	6.65e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FHL2—hematologic cancer	1.08e-05	6.63e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—hematologic cancer	1.08e-05	6.61e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—hematologic cancer	1.08e-05	6.61e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—hematologic cancer	1.07e-05	6.54e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—hematologic cancer	1.07e-05	6.53e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AGRN—hematologic cancer	1.06e-05	6.5e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—hematologic cancer	1.06e-05	6.46e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—hematologic cancer	1.05e-05	6.45e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—hematologic cancer	1.04e-05	6.37e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—hematologic cancer	1.04e-05	6.36e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—hematologic cancer	1.03e-05	6.33e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—hematologic cancer	1.03e-05	6.33e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—hematologic cancer	1.03e-05	6.32e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—hematologic cancer	1.01e-05	6.21e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—hematologic cancer	1.01e-05	6.18e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMMR—hematologic cancer	1.01e-05	6.16e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH2—hematologic cancer	1.01e-05	6.16e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—hematologic cancer	9.83e-06	6.02e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—hematologic cancer	9.78e-06	5.99e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—hematologic cancer	9.6e-06	5.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GMPS—hematologic cancer	9.58e-06	5.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PHYH—hematologic cancer	9.58e-06	5.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FTCD—hematologic cancer	9.58e-06	5.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—hematologic cancer	9.54e-06	5.85e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NCOR1—hematologic cancer	9.54e-06	5.85e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—hematologic cancer	9.53e-06	5.84e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ARNTL—hematologic cancer	9.46e-06	5.79e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—hematologic cancer	9.25e-06	5.67e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—hematologic cancer	9.23e-06	5.65e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA9—hematologic cancer	9.2e-06	5.64e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACP5—hematologic cancer	9.2e-06	5.64e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—hematologic cancer	9.13e-06	5.59e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—hematologic cancer	9.11e-06	5.58e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR2—hematologic cancer	9.08e-06	5.56e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—hematologic cancer	9.06e-06	5.55e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—hematologic cancer	8.86e-06	5.43e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—hematologic cancer	8.86e-06	5.43e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—hematologic cancer	8.8e-06	5.39e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—hematologic cancer	8.76e-06	5.37e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.76e-06	5.37e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH1—hematologic cancer	8.65e-06	5.3e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTO1—hematologic cancer	8.55e-06	5.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TXN—hematologic cancer	8.55e-06	5.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCC3—hematologic cancer	8.55e-06	5.24e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—hematologic cancer	8.52e-06	5.22e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—hematologic cancer	8.43e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—hematologic cancer	8.39e-06	5.14e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SPHK1—hematologic cancer	8.37e-06	5.13e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—hematologic cancer	8.17e-06	5.01e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—hematologic cancer	8.07e-06	4.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UGT1A1—hematologic cancer	8.04e-06	4.93e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CREBBP—hematologic cancer	7.9e-06	4.84e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CRABP1—hematologic cancer	7.82e-06	4.79e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	7.82e-06	4.79e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—hematologic cancer	7.74e-06	4.74e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—hematologic cancer	7.7e-06	4.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.66e-06	4.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DCK—hematologic cancer	7.66e-06	4.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ASNS—hematologic cancer	7.66e-06	4.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALOX5—hematologic cancer	7.62e-06	4.67e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—hematologic cancer	7.49e-06	4.59e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CREBBP—hematologic cancer	7.48e-06	4.58e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—hematologic cancer	7.39e-06	4.53e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NUP98—hematologic cancer	7.38e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—hematologic cancer	7.37e-06	4.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HDC—hematologic cancer	7.26e-06	4.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADCY7—hematologic cancer	7.17e-06	4.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA3—hematologic cancer	7.17e-06	4.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NUP214—hematologic cancer	7.12e-06	4.36e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—hematologic cancer	7.09e-06	4.34e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—hematologic cancer	7.09e-06	4.34e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3R1—hematologic cancer	7.07e-06	4.33e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—hematologic cancer	7e-06	4.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCG2—hematologic cancer	6.97e-06	4.27e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTR—hematologic cancer	6.97e-06	4.27e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO2—hematologic cancer	6.84e-06	4.19e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—hematologic cancer	6.8e-06	4.16e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3R1—hematologic cancer	6.7e-06	4.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CDA—hematologic cancer	6.64e-06	4.07e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—hematologic cancer	6.63e-06	4.06e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CREBBP—hematologic cancer	6.57e-06	4.02e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—hematologic cancer	6.53e-06	4e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—hematologic cancer	6.51e-06	3.99e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SDC1—hematologic cancer	6.48e-06	3.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PC—hematologic cancer	6.39e-06	3.91e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—hematologic cancer	6.23e-06	3.82e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—hematologic cancer	6.18e-06	3.79e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GBA—hematologic cancer	6.17e-06	3.78e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.17e-06	3.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—hematologic cancer	6.15e-06	3.77e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—hematologic cancer	6.14e-06	3.76e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3R1—hematologic cancer	5.88e-06	3.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTAP—hematologic cancer	5.64e-06	3.46e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—hematologic cancer	5.64e-06	3.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD44—hematologic cancer	5.51e-06	3.38e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NQO1—hematologic cancer	5.51e-06	3.38e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—hematologic cancer	5.43e-06	3.33e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—hematologic cancer	5.38e-06	3.29e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—hematologic cancer	5.34e-06	3.27e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—hematologic cancer	5.32e-06	3.26e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYCS—hematologic cancer	5.22e-06	3.19e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.18e-06	3.17e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—hematologic cancer	5.09e-06	3.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.03e-06	3.08e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.93e-06	3.02e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—hematologic cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.6e-06	2.82e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—hematologic cancer	4.47e-06	2.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.4e-06	2.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.35e-06	2.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA9—hematologic cancer	4.28e-06	2.62e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.28e-06	2.62e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.22e-06	2.59e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.22e-06	2.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.22e-06	2.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.02e-06	2.46e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—hematologic cancer	3.98e-06	2.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TXN—hematologic cancer	3.98e-06	2.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.98e-06	2.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.98e-06	2.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.89e-06	2.38e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—hematologic cancer	3.77e-06	2.31e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.73e-06	2.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.64e-06	2.23e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.64e-06	2.23e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.54e-06	2.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.43e-06	2.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.33e-06	2.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.33e-06	2.04e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—hematologic cancer	3.31e-06	2.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.31e-06	2.03e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—hematologic cancer	3.25e-06	1.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTR—hematologic cancer	3.24e-06	1.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.24e-06	1.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.18e-06	1.95e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.14e-06	1.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.08e-06	1.89e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—hematologic cancer	3.08e-06	1.89e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.01e-06	1.85e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.91e-06	1.78e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.76e-06	1.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—hematologic cancer	2.72e-06	1.67e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—hematologic cancer	2.7e-06	1.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.6e-06	1.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD44—hematologic cancer	2.56e-06	1.57e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.56e-06	1.57e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.41e-06	1.48e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.4e-06	1.47e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.14e-06	1.31e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—hematologic cancer	2.08e-06	1.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.02e-06	1.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—hematologic cancer	1.98e-06	1.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.96e-06	1.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.96e-06	1.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.74e-06	1.06e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.47e-06	8.98e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.46e-06	8.93e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.35e-06	8.28e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.28e-06	7.85e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—hematologic cancer	1.27e-06	7.75e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.21e-06	7.42e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.2e-06	7.33e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.12e-06	6.85e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.66e-07	5.92e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—hematologic cancer	9.21e-07	5.64e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.81e-07	4.17e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.56e-07	3.41e-06	CbGpPWpGaD
